Viewing nowCombinationZepagin Duo Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.

MFDS item code 202501741 · Approved 2025.07.10 · Insurance code 645406560
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is administered as an adjunct to diet and exercise to assist in blood sugar control in adults with type 2 diabetes. It is particularly used in patients whose blood sugar is not adequately controlled by using a combination of empagliflozin and metformin. Additionally, caution should be taken to refer to usage warnings regarding the impact on the occurrence of cardiovascular events in patients with type 2 diabetes who also have cardiovascular disease. This medication effectively improves blood sugar levels and aids in managing cardiovascular risk.
The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.
This medication is used in diabetes treatment with both components acting together to control blood sugar. When taking this medication, there is a risk of a rare side effect called severe lactic acidosis; if symptoms appear, consult a physician immediately. Additionally, caution is needed as there is a risk of hypoglycemia when taken with insulin or other diabetes medications. This medication should not be taken by patients with severely reduced kidney function or certain acute diseases. Before and after examinations that use iodine contrast agents, this medication should be temporarily discontinued and restarted only after confirming normal kidney function. In cases where surgery is scheduled, this medication should be stopped for a period before the procedure, but can be resumed after recovery. Patients with liver dysfunction, severe infections, dehydration, or poor nutritional status should use this medication with caution. It is safest for women who are pregnant or breastfeeding not to take this medication. Adverse effects such as gastrointestinal disturbances, infections, hypoglycemia, increased urination, abnormal liver function, and genitourinary infections may occur; these symptoms should be reported to a physician. Particularly, women need to pay attention to hygiene as genital infections may occur more frequently. It is advisable to regularly check kidney function and serum vitamin B12 levels when on this medication. Excessive alcohol consumption can increase the risk of adverse effects, so it should be avoided. This medication may interact with other drugs, so if other medications are being taken, please inform a physician or pharmacist. Elderly patients may have decreased kidney function, so dosage adjustments and regular monitoring are necessary. This medication is not recommended for children as safety and efficacy have not been established. In case of overdose, immediate medical attention should be sought, and dialysis may be required. This medication should be kept out of reach of children and stored in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way can help maintain the medication's effectiveness for a longer duration.
Yellow-brown, oval, double convex film-coated tablet
Bottle - 60 tablets/bottle, PTP - 60 tablets/box [(10 tablets/PTP x 6)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.